FALCON
Start date:November 2020 Main trial site:
Royal Infirmary of Edinburgh
FALCON is a multi-centre diagnostic study that aims to test the accuracy of a COVID viral detection test that hopes to lead to the development of a point-of-care diagnostic device.
Patients give two sets of samples, one swab and one swab and a saliva samples. One of these samples sets is sent for the testing via the current standard, PCR, and the other is tested using mass spectrometry.
Research Team
Caroline Blackstock
AMU Senior Research Nurse
More EMERGE Trials
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
NOVEL Study
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions
DASH Trial
DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.